The IMI Ebola+ programme was launched in response to the Ebola virus disease (EVD) outbreak that started in western Africa in 2014. The comprehensive programme contributes to efforts to tackle a wide range of challenges in Ebola research, including vaccines development, clinical trials, storage and transport, as well as diagnostics and treatments.
It is hoped that the programme, which complements work being carried out with the support of other funding bodies, will help to make a difference in the current and future outbreaks. In addition to Ebola, the programme will also address related diseases, such as Marburg. 12 projects, with a total budget of over €200 million, have been selected for funding under the first Ebola+ Call for proposals.
Vaccine development projects
- EBOVAC 1, EBOVAC2 and EBOVAC3
Vaccine manufacture capability projects
Deployment of and compliance with vaccination regimens projects
Rapid diagnostic test projects
For more information on the other Ebola+ projects: